Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT04995094
Brief Title: Study of Neoadjuvant Imprime PGG and Pembrolizumab for Stage III, Resectable Melanoma

First Submitted : July 19, 2021
First Submitted that Met QC Criteria : August 2, 2021
First Posted : August 6, 2021

Last Update Submitted that Met QC Criteria : October 29, 2021
Last Update Posted : November 5, 2021